Trial Profile
Planned US trial of NBTXR 3 intratumoral implant (activated by radiotherapy) for the treatment of cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2012
Price :
$35
*
At a glance
- Drugs Hafnium oxide (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 29 Nov 2012 New trial record